1. Orozco J. Axicabtagene Ciloleucel: The First FDA-Approved CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma;King;J. Adv. Pract. Oncol.,2019
2. The Emerging Landscape of Immune Cell Therapies;Weber;Cell,2020
3. [press release]. (2017). FDA Approves CAR-T Cell Therapy to Treat Adults with Certain Types of Large B-Cell Lymphoma.
4. Key Statistics for Non-hodgkin Lymphoma,2023
5. Overview of approved CAR-T therapies, ongoing clinical trials, and its impact on clinical practice;Sengsayadeth;EJH,2021